尼索地平对表观肝血流量和有效肾血浆流量的影响。
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.
作者信息
Meredith P A, Pasanisi F, Elliott H L, Reid J L
出版信息
Br J Clin Pharmacol. 1985 Sep;20(3):235-7. doi: 10.1111/j.1365-2125.1985.tb05066.x.
Abstract
The effects of the acute and continued administration of the calcium antagonist nisoldipine on hepatic and renal blood flow and on renal function were studied in nine normotensive volunteers. There were no significant changes in supine blood pressure or heart rate but acute administration significantly increased both apparent liver blood flow and effective renal plasma flow. With continued administration these increases were attenuated and were not significantly different from placebo after 4 days treatment. Acute nisoldipine administration was also associated with significant increases in glomerular filtration rate and urinary sodium excretion.
摘要
在9名血压正常的志愿者中研究了钙拮抗剂尼索地平急性和持续给药对肝血流量、肾血流量及肾功能的影响。仰卧位血压或心率无显著变化，但急性给药显著增加了表观肝血流量和有效肾血浆流量。持续给药后，这些增加减弱，治疗4天后与安慰剂相比无显著差异。急性给予尼索地平还与肾小球滤过率和尿钠排泄显著增加有关。
相似文献
1
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.尼索地平对表观肝血流量和有效肾血浆流量的影响。
Br J Clin Pharmacol. 1985 Sep;20(3):235-7. doi: 10.1111/j.1365-2125.1985.tb05066.x.
2
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.由肝血流反应差异引起的尼索地平药代动力学变异性。
J Clin Pharmacol. 1989 Aug;29(8):714-21. doi: 10.1002/j.1552-4604.1989.tb03405.x.
3
Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
J Cardiovasc Pharmacol. 1989 Jan;13(1):90-3.
4
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.尼索地平引起的肝血流变化对其口服给药后药代动力学的影响。
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
5
The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.新型钙拮抗剂尼索地平在血压正常和高血压受试者中的药效学和药代动力学。
Eur J Clin Pharmacol. 1985;29(1):21-4. doi: 10.1007/BF00547363.
6
Renal clearance and micropuncture studies of nisoldipine effects in spontaneously hypertensive rats.尼索地平对自发性高血压大鼠作用的肾清除率及微穿刺研究
J Cardiovasc Pharmacol. 1987;9 Suppl 1:S24-31.
7
Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
Arzneimittelforschung. 1986 Dec;36(12):1736-9.
8
Inhibitory effect of nisoldipine on angiotensin-II-induced renal actions in anesthetized dogs.尼索地平对麻醉犬血管紧张素II诱导的肾脏作用的抑制效应。
J Cardiovasc Pharmacol. 1989 Jul;14(1):96-102. doi: 10.1097/00005344-198907000-00017.
9
10
Verapamil pharmacokinetics and apparent hepatic and renal blood flow.维拉帕米的药代动力学及表观肝血流量和肾血流量
Br J Clin Pharmacol. 1985 Aug;20(2):101-6. doi: 10.1111/j.1365-2125.1985.tb05038.x.
引用本文的文献
1
Clinical pharmacokinetics of nisoldipine coat-core.尼索地平包芯片的临床药代动力学
Clin Pharmacokinet. 1998 Sep;35(3):191-208. doi: 10.2165/00003088-199835030-00003.
2
Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.硝苯地平引起的血浆普萘洛尔增加取决于普萘洛尔的给药速率。
Eur J Clin Pharmacol. 1995;49(1-2):121-5. doi: 10.1007/BF00192370.
3
Drug interactions with thrombolytic agents. Current perspectives.与溶栓药物的药物相互作用。当前观点
Clin Pharmacokinet. 1995 Apr;28(4):315-26. doi: 10.2165/00003088-199528040-00004.
4
Verapamil pharmacokinetics.维拉帕米的药代动力学。
Br J Clin Pharmacol. 1986 May;21(5):554-5. doi: 10.1111/j.1365-2125.1986.tb02846.x.
5
Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.硝苯地平在正常志愿者中的药代动力学和药效学。
Br J Clin Pharmacol. 1987 Jun;23(6):693-701. doi: 10.1111/j.1365-2125.1987.tb03103.x.
6
Clinical pharmacokinetics of nicotine.尼古丁的临床药代动力学
Clin Pharmacokinet. 1987 Jan;12(1):30-40. doi: 10.2165/00003088-198712010-00003.
7
Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.尼索地平对地高辛血流动力学效应及血浆浓度的影响。
Br J Clin Pharmacol. 1986 Aug;22(2):155-9. doi: 10.1111/j.1365-2125.1986.tb05243.x.
8
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.输注速率对尼索地平在人体中的药代动力学及血流动力学效应的影响。
Br J Clin Pharmacol. 1988 Jun;25(6):709-17. doi: 10.1111/j.1365-2125.1988.tb05257.x.
9
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.尼索地平。对其药效学、药代动力学特性以及治疗心绞痛、高血压和相关心血管疾病的疗效的初步综述。
Drugs. 1988 Dec;36(6):682-731. doi: 10.2165/00003495-198836060-00003.
10
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.尼索地平引起的肝血流变化对其口服给药后药代动力学的影响。
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
本文引用的文献
1
[Effects of intravenous nicardipine hydrochloride (YC 93), a calcium antagonist, on renal function (author's transl)].钙拮抗剂盐酸尼卡地平（YC 93）静脉注射对肾功能的影响（作者译）
Nihon Jinzo Gakkai Shi. 1981 Aug;23(8):1143-51.
2
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.食物对肝血流量的影响：对“食物效应”现象的启示
Clin Pharmacol Ther. 1983 Sep;34(3):316-23. doi: 10.1038/clpt.1983.174.
3
Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.硝苯地平可增加正常受试者的肝脏表观血流量，而硝酸甘油则使其降低。
Br J Clin Pharmacol. 1984 Jan;17(1):83-5. doi: 10.1111/j.1365-2125.1984.tb05003.x.
4
Clinical effects of intravenous nifedipine on renal function.静脉注射硝苯地平对肾功能的临床疗效。
J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):67-71. doi: 10.1097/00005344-198301000-00010.
5
Verapamil pharmacokinetics and apparent hepatic and renal blood flow.维拉帕米的药代动力学及表观肝血流量和肾血流量
Br J Clin Pharmacol. 1985 Aug;20(2):101-6. doi: 10.1111/j.1365-2125.1985.tb05038.x.
6
Drug kinetics and hepatic blood flow.药物动力学与肝血流量
Clin Pharmacokinet. 1979 Nov-Dec;4(6):433-48. doi: 10.2165/00003088-197904060-00003.
Zotero 插件